Schroder Investment Management Group’s Kite Pharma, Inc. KITE Stock Holding History

Schroder Investment Management Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,444	Closed	-$472K	–	1214
2016 Q3	$472K	Sell	8,444 -16,011	-65%	-$892K	﹤0.01%	979
2016 Q2	$1.22M	Hold	24,455	–	–	﹤0.01%	880
2016 Q1	$1.08M	Buy	24,455 +12,593	+106%	+$610K	﹤0.01%	906
2015 Q4	$731K	Buy	+11,862	New	+$835K	﹤0.01%	945

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Schroder Investment Management Group's KITE Position: Q4 2016 in Review

Schroder Investment Management Group sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 8,444 shares — an estimated $472K sold.

Schroder Investment Management Group first reported a position in KITE in Q4 2015 and held it in 4 quarters. The position peaked at $1.22M in Q2 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

Schroder Investment Management Group reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
Schroder Investment Management Group sold 8,444 Kite Pharma, Inc. shares in Q4 2016, an estimated $472K.
Schroder Investment Management Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 4 quarters.
Schroder Investment Management Group's Kite Pharma, Inc. position peaked at $1.22M in Q2 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Schroder Investment Management Group's 13F filing for Q4 2016, filed 10 Feb 2017.